|
PCRX | Pacira Biosciences, Inc. |
|
|
PCRX | Pacira Biosciences, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.66 |
| Leverage | 43.96% |
| Market Cap | $ 1.1B |
| PE | 55.86 |
| Dividend Yield | 0.00% |
| Profit | $ 19.7m |
| Margin | 3.77% |
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United States. The company is headquartered in Parsippany, New Jersey.